Table 1

Patients' characteristics

VariableNo.
Total, no. (%) 71 (100) 
Median age at MM diagnosis, y (range) 70 (58-81) 
Male sex, no. (%) 50 (71.4) 
Race/ethnicity, no. (%)  
    White 65 (92.9) 
    African American 3 (4.3) 
    Pacific Islanders 1 (1.4) 
    Hispanic 1 (1.4) 
Calendar year at MM diagnosis, median (range) 2002 (1997-2005) 
Latency between blood draw and subsequent MM dx (mo), median (range)*  
    First prediagnostic blood draw 59 (29-118) 
    Last prediagnostic blood draw 32 (24-84) 
Median number (range) of available prediagnostic serum samples per persons 3 (1-6) 
VariableNo.
Total, no. (%) 71 (100) 
Median age at MM diagnosis, y (range) 70 (58-81) 
Male sex, no. (%) 50 (71.4) 
Race/ethnicity, no. (%)  
    White 65 (92.9) 
    African American 3 (4.3) 
    Pacific Islanders 1 (1.4) 
    Hispanic 1 (1.4) 
Calendar year at MM diagnosis, median (range) 2002 (1997-2005) 
Latency between blood draw and subsequent MM dx (mo), median (range)*  
    First prediagnostic blood draw 59 (29-118) 
    Last prediagnostic blood draw 32 (24-84) 
Median number (range) of available prediagnostic serum samples per persons 3 (1-6) 

dx indicates diagnosis.

*

Latency interval (mo) between the first and the last prediagnostic blood draw in relation to a subsequent MM diagnosis.

Blood samples were prospectively collected on an annual basis; blood was drawn up to 6 sequential years for each individual.